Exelixis (EXEL) Current Deferred Revenue (2010 - 2023)

Exelixis' Current Deferred Revenue history runs 14 years deep, the most recent figure standing at $13.5 million for Q2 2023.

• On a quarterly basis, Current Deferred Revenue fell 8.13% year-over-year to $13.5 million in Q2 2023; TTM through Jun 2023 was $13.5 million, a 8.13% decrease from a year earlier, with the FY2022 full-year figure at $14.1 million, down 15.0% from the prior year.
• Current Deferred Revenue climbed to $13.5 million in Q2 2023 per EXEL's latest filing, from $13.4 million in the prior quarter.
• Across five years, Current Deferred Revenue topped out at $19.0 million in Q2 2021 and bottomed at $321000.0 in Q2 2019.
• The 5-year median for Current Deferred Revenue is $13.8 million (2022), against an average of $12.1 million.
• Across the five-year window, Current Deferred Revenue sank 94.6% in 2019 and surged 4977.88% in 2020, its largest moves.
• Year by year, Current Deferred Revenue stood at $8.2 million in 2019, then grew by 29.27% to $10.6 million in 2020, then jumped by 56.16% to $16.6 million in 2021, then dropped by 15.0% to $14.1 million in 2022, then dropped by 3.87% to $13.5 million in 2023.
• Per Business Quant, the three latest EXEL Current Deferred Revenue figures stand at $13.5 million (Q2 2023), $13.4 million (Q1 2023), and $14.1 million (Q4 2022).